Myomo Inc
myomo.comWhat Do They Do?
Sells MyoPro powered arm braces, custom-fitted for people with neuromuscular conditions or upper-limb paralysis, to help them move their arms and hands.
10-K for FY2025, filed Mar 9, 2026
How Do They Make Money?
Myomo bills patients’ insurers for a one-time brace after delivery and initial instruction; O&P providers and the VA buy devices at agreed prices, with sales tied to shipment or delivery depending on the arrangement.
10-K for FY2025, filed Mar 9, 2026The Company derives the majority of its revenue from direct billing. The Company also derives revenue from the sale of its products to…View ↗
The product has been delivered to the patient, including completion of initial instruction on its use.View ↗
The transaction price associated with the MyoPro for direct to patient revenue is generally determined by the insurance payer. For patients…View ↗
For revenues derived from O&P providers in the United States and internationally and the VA, the Company recognizes revenue when control…View ↗
$40.9M
-
10-K for FY2025, filed Mar 9, 2026
$40.9M ↗
Who Are Their Customers?
Myomo supplies devices directly to patients and bills their insurers; O&P providers and the VA also provide devices to patients, while hospitals and clinics refer candidates.
10-K for FY2025, filed Mar 9, 2026We are a wearable medical robotics company that offers functional improvement for those with neuromuscular disorders and upper limb…View ↗
To assess whether an individual is a medically-qualified candidate for a MyoPro, we and our channel partners utilize a variety of…View ↗
To generate awareness and interest in our products, we advertise on television and through social media. In addition, our clinical teams…View ↗
Do Revenues Turn Into Profits?
No. It lost $15.6M in FY2025.
10-K for FY2025, filed Mar 9, 2026
−$14.4MView ↗
10-K for FY2025, filed Mar 9, 2026
−$15.6MView ↗
10-K for FY2025, filed Mar 9, 2026
−$16.3MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 5, 2026
−$4MView ↗
- ▼ −13% (Loss)
- vs −$4.6M in Q2 FY2025
-
Aug 5, 2026
Raises full-year revenue guidance to $45 million to $47 million
Sources
8-K, filed Aug 5, 2026
"In the third quarter of 2026, we expect continued year-over-year revenue growth with modestly higher operating expenses on a sequential…View ↗
Growing. Revenue grew 3.0x in 4 years, from $13.9M in FY2021 to $40.9M in FY2025, about 31% a year.
Medicare payment basis
The older report described Medicare reimbursement as rental under a capped program; the latest says the MyoPro is classified as a brace and can be reimbursed in a lump sum.
10-K for FY2022, filed Mar 13, 2023 10-K for FY2025, filed Mar 9, 2026In most cases, private health insurance companies pay for the MyoPro device, either to us directly or to an O&P provider depending on the…View ↗
In many cases, private health insurance companies reimburse providers for the MyoPro device. If we are serving the patient directly, then…View ↗
Who Do They Compete With?
Competes with Lifeward, Ekso Bionics, Cyberdyne, MicroTransponder, Neurolutions, Vincent Systems, and HKK Bionics
10-K for FY2025, filed Mar 9, 2026During the last few years, a number of companies have emerged to provide exoskeleton suits that enable those with lower extremity paralysis…View ↗
Loading...
